Drugs Made In America Acquisition Corp. (DMAAU)Financial Services | Shell Companies | Fort Lauderdale, United States | NasdaqGM
10.58 USD
Short-term: ☆☆☆☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 18, 2026, 10:26 p.m. EDT
High-risk shell company with negligible trading volume and deteriorating fundamentals (negative book value, negative cash flow) making it statistically favor heavy puts or avoidance entirely. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.002858 |
| MSTL | 0.003456 |
| AutoTheta | 0.004978 |
| AutoARIMA | 0.007748 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 40% |
| H-stat | 2535.26 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.760 |
| Excess Kurtosis | -0.29 |
| Attribute | Value |
|---|---|
| Sector | Financial Services |
| Market Cap | 308,639,264 |
| Website | https://dmaacorp.com |
| Attribute | Value |
|---|---|
| 52 Week Change | 0.04134798 |
| Address1 | 1 East Broward Boulevard |
| Address2 | Suite 700 |
| All Time High | 10.82 |
| All Time Low | 10.0 |
| Ask | 10.13 |
| Ask Size | 167 |
| Average Daily Volume10 Day | 210 |
| Average Daily Volume3 Month | 68 |
| Average Volume | 68 |
| Average Volume10Days | 210 |
| Bid | 10.54 |
| Bid Size | 1 |
| Book Value | -0.219 |
| City | Fort Lauderdale |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 10.5802 |
| Current Ratio | 0.032 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 10.5802 |
| Day Low | 10.5802 |
| Display Name | Drugs Made In America |
| Earnings Timestamp End | 1,747,771,200 |
| Earnings Timestamp Start | 1,747,771,200 |
| Ebitda Margins | 0.0 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 10.526462 |
| Fifty Day Average Change | 0.053738594 |
| Fifty Day Average Change Percent | 0.005105096 |
| Fifty Two Week Change Percent | 4.134798 |
| Fifty Two Week High | 10.6043 |
| Fifty Two Week High Change | -0.02409935 |
| Fifty Two Week High Change Percent | -0.0022726017 |
| Fifty Two Week Low | 10.0 |
| Fifty Two Week Low Change | 0.5802002 |
| Fifty Two Week Low Change Percent | 0.058020018 |
| Fifty Two Week Range | 10.0 - 10.6043 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,738,074,600,000 |
| Free Cashflow | -1,519,595 |
| Full Exchange Name | NasdaqGM |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.17878 |
| Held Percent Institutions | 0.02599 |
| Industry | Shell Companies |
| Industry Disp | Shell Companies |
| Industry Key | shell-companies |
| Ipo Expected Date | 2,025-01-28 |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in Fort Lauderdale, Florida. |
| Long Name | Drugs Made In America Acquisition Corp. |
| Market | us_market |
| Market Cap | 308,639,264 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_1889535116 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | 5,940,643 |
| Next Fiscal Year End | 1,798,675,200 |
| Open | 10.57 |
| Operating Cashflow | -539,187 |
| Operating Margins | 0.0 |
| Phone | 954 870 3099 |
| Previous Close | 10.5802 |
| Price Hint | 2 |
| Price To Book | -48.311417 |
| Profit Margins | 0.0 |
| Quick Ratio | 0.016 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.0 |
| Regular Market Change Percent | 0.0 |
| Regular Market Day High | 10.5802 |
| Regular Market Day Low | 10.5802 |
| Regular Market Day Range | 10.5802 - 10.5802 |
| Regular Market Open | 10.57 |
| Regular Market Previous Close | 10.5802 |
| Regular Market Price | 10.5802 |
| Regular Market Time | 1,775,678,400 |
| Regular Market Volume | 1 |
| Return On Assets | -0.01464 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Financial Services |
| Sector Disp | Financial Services |
| Sector Key | financial-services |
| Shares Outstanding | 29,171,400 |
| Shares Short | 1,496 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 1,594 |
| Short Name | Drugs Made In America Acquisiti |
| Short Ratio | 299.2 |
| Source Interval | 15 |
| State | FL |
| Symbol | DMAAU |
| Total Cash | 6,137 |
| Total Debt | 0 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 10.514869 |
| Two Hundred Day Average Change | 0.06533146 |
| Two Hundred Day Average Change Percent | 0.0062132454 |
| Type Disp | Equity |
| Volume | 1 |
| Website | https://dmaacorp.com |
| Zip | 33,301 |